HIV pre-exposure prophylaxis for adolescents and young adults

Post date: August 2017

This review describes the evidence for HIV preexposure prophylaxis (PrEP) with daily combined tenofovir disoproxil fumarate and emtricitabine for adolescents and young adults. Current recommendations are described, as are the unique medical, socioeconomic, and legal considerations regarding the use of PrEP for youth.

Resource type
Journal & research articles, Literature reviews
Allen, E., Gordon, A., Krakower, D., Hsu, K.
Year of publication